Comparison of Two-treadmill Test Protocols to Evaluate Endurance in People With Cancer

This study has been completed.

Sponsor:

Collaborator:

McMaster University

Information provided by (Responsible Party):

Oren Cheifetz, McMaster University

ClinicalTrials.gov Identifier:

NCT01111032

First received: April 26, 2010

Last updated: September 29, 2013

Last verified: September 2013

History of Changes

Purpose

During this study the investigators will compare the use of two treadmill tests in people diagnosed with cancer. The STEEP treadmill protocol is often used to evaluate the endurance of people diagnosed with cancer, however, since it is based on step increases in speed or ramp, it may not related to normal function. The new test, which is based on the body response to increased activity has not been used with people with cancer but may provide a better approximation of endurance demands during daily function. Our question is whether the new treadmill test can be used to evaluate aerobic function with people with cancer better than the STEEP treadmill test.

Condition
Cancer


Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	Comparison of Two-treadmill Test Protocols to Evaluate Endurance in People With Cancer.

Resource links provided by NLM:

MedlinePlus related topics: Cancer

U.S. FDA Resources

Further study details as provided by McMaster University:

Primary Outcome Measures:

STEEP treadmill test [ Time Frame: 1 hour ] [ Designated as safety issue: No ]
Treadmill test for endurance. Lasts approx 15 min with 45 min recovery


Enrollment:	12
Study Start Date:	May 2011
Study Completion Date:	December 2011
Primary Completion Date:	October 2011 (Final data collection date for primary outcome measure)

Groups/Cohorts
Treadmill test

Eligibility


Ages Eligible for Study:	16 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Adult well cancer survivors

Criteria

Inclusion Criteria:

Participants are required to be adults (age 16 or over),
Diagnosed with cancer, at any stage of treatment (during or after treatment),
Able to follow instructions in English, and provide informed consent.
Participants need to be considered "well" to participate. A "well participant" has been defined as a cancer survivor who is living at home, able to ambulate independently without a gait aid (single point cane is acceptable), has no acute medical conditions, and passes pre-exercise safety screening.

Exclusion Criteria:

Cancer survivors with metastatic disease.
Cancer survivors who are defined as unwell.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01111032

Locations


Canada, Ontario
Hamilton Health Sciences, Henderson Campus
Hamilton, Ontario, Canada, L8V 1C3

Sponsors and Collaborators

Hamilton Health Sciences Corporation

McMaster University

Investigators


Principal Investigator:	Oren Cheifetz, M.Sc. PT	Hamilton Health Sciences Corporation

More Information

No publications provided


Responsible Party:	Oren Cheifetz, Clinical Specialist - Physiotherapy, McMaster University
ClinicalTrials.gov Identifier:	NCT01111032 History of Changes
Other Study ID Numbers:	Treadmill Comparison
Study First Received:	April 26, 2010
Last Updated:	September 29, 2013
Health Authority:	Canada: Ethics Review Committee

Keywords provided by McMaster University:


Treadmill Exercise Cancer Validity Reliability

ClinicalTrials.gov processed this record on February 27, 2015

To Top